Roles of complex gangliosides at the neuromuscular junction.
Bullens
R W M
RW
Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
O'Hanlon
G M
GM
Wagner
E
E
Molenaar
P C
PC
Furukawa
Koichi
K
Furukawa
Keiko
K
Plomp
J J
JJ
Willison
H J
HJ
D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D001323:Autoantibodies / Q000494:pharmacology; D019274:Botulinum Toxins, Type A / Q000494:pharmacology; D004558:Electric Stimulation; D019706:Excitatory Postsynaptic Potentials / Q000187:drug effects / Q000502:physiology; D005732:Gangliosides / Q000276:immunology / Q000502:physiology*; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D019846:Miller Fisher Syndrome / Q000097:blood / Q000276:immunology; D017350:N-Acetylgalactosaminyltransferases / Q000235:genetics*; D009465:Neuromuscular Agents / Q000494:pharmacology; D009469:Neuromuscular Junction / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D010791:Phrenic Nerve / Q000502:physiology
D000906:Antibodies; D001323:Autoantibodies; D005732:Gangliosides; D009465:Neuromuscular Agents; C026226:ganglioside, GD3; C039129:GQ1b ganglioside; D017350:N-Acetylgalactosaminyltransferases; C023220:(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase; D019274:Botulinum Toxins, Type A